Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging strategies for treating gout
Edward M. Huddleston, Angelo Gaffo
Current Opinion in Pharmacology (2022) Vol. 65, pp. 102241-102241
Closed Access | Times Cited: 21

Showing 21 citing articles:

Recent advances in gout drugs
Cheng Shi, Ziting Zhou, Xiaowei Chi, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114890-114890
Closed Access | Times Cited: 41
Polymeric nanoparticles-based targeted delivery of drugs and bioactive compounds for arthritis management
Tanu Dixit, Anuradha Vaidya, Selvan Ravindran
Future Science OA (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Geraniin restricts inflammasome activation and macrophage pyroptosis by preventing the interaction between ASC and NLRP3 to exert anti-inflammatory effects
Xiaoyi Zhou, Minyan Qin, Leran He, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111656-111656
Closed Access | Times Cited: 5
Modified Baihu decoction therapeutically remodels gut microbiota to inhibit acute gouty arthritis
Xianyang Wang, Haishan Long, Ming Chen, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 22
In Silico Prediction of Maize microRNA as a Xanthine Oxidase Inhibitor: A New Approach to Treating Hyperuricemia Patients
Manas Joshi, Mohd Mabood Khan
Non-Coding RNA (2025) Vol. 11, Iss. 1, pp. 6-6
Open Access
Advancements in Uricase formulations: overcoming therapeutic challenges in enzyme replacement therapy
Woo Ho Cho, HyeSoon Kim, So‐Yeol Yoo, et al.
Journal of Pharmaceutical Investigation (2025)
Open Access
Screening of urate-lowering components in TongFengTangSan using an integrated strategy of affinity ultrafiltration, molecular docking and in vitro validation
Junying Wu, Qiong An, Zheng‐Gen Liao, et al.
CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (CHINESE VERSION) (2025), pp. 100551-100551
Open Access
Identification of 5-[5-cyano-1-(pyridin-2-ylmethyl)-1H-indole-3-carboxamido] thiazole-4-carboxylic acid as a promising dual inhibitor of urate transporter 1 and xanthine oxidase
Fengwei Lin, Ming Sun, Jun Gao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115532-115532
Closed Access | Times Cited: 9
Gout Management Using Nanocarrier Systems: A Review
Chia Wen Qi, Ummu Umaimah Mohd Nordin, Syed Mahmood, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 9, pp. 9816-9846
Closed Access | Times Cited: 3
Pharmacotherapies in Dupuytren Disease: Current and Novel Strategies
Alex G. Lambi, Steven N. Popoff, Prosper Benhaim, et al.
The Journal Of Hand Surgery (2023) Vol. 48, Iss. 8, pp. 810-821
Open Access | Times Cited: 8
Unlocking the potential of tranilast: Targeting fibrotic signaling pathways for therapeutic benefit
Gaelle Massoud, Gaelle Massoud, Gaelle Massoud, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112423-112423
Closed Access | Times Cited: 2
Development of a novel anti-inflammatory recombinant uricase with extended half-life for gout therapy
Ziang Zhang, Nannan Fu, Qinkai Li, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 666, pp. 115-121
Closed Access | Times Cited: 4
A Manajemen Fisioterapi pada Suspek Gout Arthritis : Laporan Kasus
Yery Mustari, Melda Putri, Christine Milenia Sarira, et al.
Jurnal Fisioterapi dan Rehabilitasi (2024) Vol. 8, Iss. 2, pp. 161-169
Open Access | Times Cited: 1
An update on the pharmacotherapy of gout
Jack Shi Jie Yuan, A. N. Shashidhara, Aman Sutaria, et al.
Expert Opinion on Pharmacotherapy (2024), pp. 1-9
Closed Access | Times Cited: 1
The preventive effect of Chinese sumac fruit against monosodium urate-induced gouty arthritis in rats by regulating several inflammatory pathways
Nan Ma, Yuanyue Zhang, Tao Wang, et al.
Food & Function (2022) Vol. 14, Iss. 2, pp. 1148-1159
Closed Access | Times Cited: 7
New xanthine oxidase inhibitor from white mulberry (Morus alba L.) – anti-gout prospective study
Suresh J. Antony, Rushika J. Mehta, Soosaimanickam Maria Packiam, et al.
Zeitschrift für Physikalische Chemie (2023) Vol. 237, Iss. 11, pp. 1885-1905
Closed Access | Times Cited: 3
Design, synthesis, and biological studies of dual URAT1 inhibitor and FXR agonist based on benzbromarone
Wanqiu Huang, Shixuan Jiao, Siliang Chen, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 75, pp. 117073-117073
Closed Access | Times Cited: 5
Effect of Xanthohumol from Humulus lupulus L. Against Gouty Bone Damage in Arthritis of Rats Induced by Mono-sodium Urate
Jianyong Han, Tianshuang Xia, Yiping Jiang, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3425-3435
Closed Access
Synthesis and Biological Evaluation of Novel Chlorogenic Acid–Apigenin Conjugates as Anti-acute Gout Agents
Changjiang Xu, Ling Li, Zheng Liu, et al.
Chemical and Pharmaceutical Bulletin (2024) Vol. 72, Iss. 8, pp. 751-761
Open Access
A Closed‐Loop Cascade Strategy for On‐Demand Regulation of Uric Acid
Chenyao Nie, Ji Xu, Yuhui Zhao, et al.
Advanced Healthcare Materials (2024)
Closed Access
Longitudinal analysis of serum urate in prediabetic phase
Javier Marrugo, L Santacroce, Misti L. Paudel, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 11, pp. 2976-2980
Closed Access
Research hotspots and trends related to pain in gouty arthritis from 2014 to 2024: A bibliometric analysis
Chengyin Lu, Yuxing Guo, Zhiqiang Luo, et al.
Medicine (2024) Vol. 103, Iss. 46, pp. e40525-e40525
Open Access
Page 1

Scroll to top